source
- Servier to acquire Edgewise Therapeutics' muscular dystrophy program for up to $2.65 billionFrench pharma group Servier announced it will purchase Edgewise Therapeutics' muscular dystrophy business. The transaction is valued at up to $2.65 billion, comprising a $1.55 billion upfront cash…
- Eli Lilly gives hospitals five days to submit 340B claims data or lose discount pricingEli Lilly has issued a notice to more than 1,000 hospitals that take part in the federal 340B drug discount program, requiring them to provide comprehensive claims data within five days. The compa…